The oxytocin-induced inward current in vagal neurons of the rat is mediated by G protein activation but not by an increase in the intracellular calcium concentration

Eur J Neurosci. 1997 Dec;9(12):2605-12. doi: 10.1111/j.1460-9568.1997.tb01690.x.

Abstract

The neuropeptide oxytocin can depolarize parasympathetic preganglionic neurons in the dorsal motor nucleus of the vagus nerve of the rat by generating a sustained inward current, which is sodium-dependent and tetrodotoxin-insensitive. The second messenger activated by oxytocin receptor binding is, however, not yet known. In the present study, we attempted to characterize it by using the whole-cell recording technique and brainstem slices. When loaded with GTP-gamma-S, a non-hydrolysable analogue of GTP, vagal neurons generated a persistent inward current in the absence of agonist and the oxytocin effect was suppressed, suggesting that the peptide-evoked current was mediated by G-protein activation. Loading vagal neurons with the calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N',-tetraacetic acid (BAPTA) suppressed a calcium-dependent, slowly decaying potassium aftercurrent but did not affect the oxytocin response, suggesting that the latter was not mediated by an agonist-induced increase in the intracellular calcium concentration. Protein kinase C (PKC) activation was probably not involved, since the peptide-evoked current was not modified by loading neurons with the PKC inhibitor H7. Thus, the oxytocin-evoked current in vagal neurons was probably not mediated by phospholipase C-beta (PLC-beta) activation. Loading neurons with 8-Br-cAMP or with an adenylyl cyclase activator (forskolin) reduced the oxytocin-evoked current by about half. SQ 22536, an adenylyl cyclase inhibitor, reduced this current by a similar amount. However, the peptide-evoked current was unaffected by Rp-cAMPS and Sp-cAMPS, an inhibitor and an activator, respectively, of cAMP-dependent protein kinase (PKA). We suggest that oxytocin activates two distinct signalling pathways in vagal neurons: one which is cAMP-dependent, but PKA-independent, and one, unidentified, which is PLC-beta-and cAMP-independent. Each pathway accounts for about half of the peptide effect and both appear to involve G-protein activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Animals
  • Brain Stem / cytology
  • Buffers
  • Calcium / metabolism*
  • Colforsin / pharmacology
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / metabolism
  • Cyclic AMP / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Excitatory Amino Acid Agonists / pharmacology
  • GTP-Binding Proteins / metabolism*
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Hippocampus / cytology
  • Hippocampus / metabolism
  • Male
  • N-Methylaspartate / pharmacology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / physiology
  • Oxytocin / pharmacology*
  • Patch-Clamp Techniques
  • Rats
  • Rats, Sprague-Dawley
  • Thionucleotides / pharmacology
  • Vagus Nerve / cytology
  • Vagus Nerve / drug effects
  • Vagus Nerve / physiology*

Substances

  • Buffers
  • Enzyme Inhibitors
  • Excitatory Amino Acid Agonists
  • Thionucleotides
  • Colforsin
  • 8-Bromo Cyclic Adenosine Monophosphate
  • adenosine-3',5'-cyclic phosphorothioate
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Oxytocin
  • N-Methylaspartate
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Cyclic AMP
  • GTP-Binding Proteins
  • Calcium